Phase II Trial PD-L1/PD-1 Blockade Avelumab (MSB0010718C) With Chemoradiotherapy for Locally Advanced Resectablet3b-4/N1-2 Rectal Cancer (Averec Trial)

  • Segelov, Eva (Primary Chief Investigator (PCI))

Project: Other

Project Details

StatusFinished
Effective start/end date12/02/19 → 11/02/24

Clinical Trial Phase

  • Phase II